CD8A and colorectal carcinoma: In terms of interferon signaling and antitumor immune populations, particularly the dense infiltration of CD8+ cytotoxic T lymphocytes, it predicts an increased likelihood of response to immune checkpoint inhibitors in CRC patients (54).